Compare RGC & ACM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGC | ACM |
|---|---|---|
| Founded | 2014 | 1980 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Military/Government/Technical |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 11.2B |
| IPO Year | 2020 | 2007 |
| Metric | RGC | ACM |
|---|---|---|
| Price | $29.85 | $84.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $132.70 |
| AVG Volume (30 Days) | 153.8K | ★ 917.7K |
| Earning Date | 10-31-2025 | 05-04-2026 |
| Dividend Yield | N/A | ★ 1.45% |
| EPS Growth | N/A | ★ 42.71 |
| EPS | N/A | ★ 0.56 |
| Revenue | N/A | ★ $16,139,622,000.00 |
| Revenue This Year | N/A | $4.54 |
| Revenue Next Year | N/A | $5.71 |
| P/E Ratio | ★ N/A | $152.98 |
| Revenue Growth | N/A | ★ 0.21 |
| 52 Week Low | $9.39 | $83.02 |
| 52 Week High | $950.00 | $135.52 |
| Indicator | RGC | ACM |
|---|---|---|
| Relative Strength Index (RSI) | 56.59 | 36.04 |
| Support Level | $12.29 | N/A |
| Resistance Level | $36.75 | $100.41 |
| Average True Range (ATR) | 3.89 | 2.77 |
| MACD | 0.77 | -0.30 |
| Stochastic Oscillator | 42.66 | 17.23 |
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Aecom is one of the largest global providers of advisory, design, and engineering services. It serves a broad spectrum of end markets including water, transportation, and environment. Based in Dallas, Aecom employs 51,000. The company generated $16.1 billion in sales in fiscal 2025.